References

Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis

10.1016/s2214-109x(17)30393-5 · 2017 · External reference

Age-related macular degeneration

10.1016/s0140-6736(18)31550-2 · 2018 · External reference

Geographic atrophy: clinical features and potential therapeutic approaches

10.1016/j.ophtha.2013.11.023 · 2014 · External reference

Relationship between RPE and choriocapillaris in age-related macular degeneration

10.1167/iovs.09-3639 · 2009 · External reference

The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration

10.1016/j.ophtha.2017.08.038 · 2018 · External reference

Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration

10.1016/j.ophtha.2017.11.036 · 2018 · External reference

How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review

10.1136/bmjopen-2016-011504 · 2016 · External reference

Cognitive impairment in age-related macular degeneration and geographic atrophy

10.1016/j.ophtha.2012.04.026 · 2012 · External reference

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

10.1016/s0140-6736(23)01520-9 · 2023 · External reference

C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial

10.1016/j.ophtha.2020.08.027 · 2021 · External reference

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

10.1016/s0140-6736(23)01583-0 · 2023 · External reference

Treatment of dry age-related macular degeneration: A review

10.1111/ceo.14294 · 2023 · External reference

Progress in evidence-based medicine: a quarter century on

10.1016/s0140-6736(16)31592-6 · 2017 · External reference

Complement inhibitors for age-related macular degeneration

2023 · External reference

The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis

10.1016/j.survophthal.2023.11.008 · 2024 · External reference

Efficacy and safety of complement inhibitors in patients with geographic atrophy associated with age-related macular degeneration: a network meta-analysis of randomized controlled trials

10.3389/fphar.2024.1410172 · 2024 · External reference

Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration

2020 · External reference

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

10.1186/2046-4053-4-1 · 2015 · External reference

OphthoEvidence Report: Comparative effects of treatments for geographic atrophy secondary to age-related macular degeneration: a protocol for a living systematic review and network meta-analysis

2026 · External reference

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations

10.7326/m14-2385 · 2015 · External reference

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

2021 · External reference

Chapter 23: Including variants on randomized trials [last updated October 2019].

2024 · External reference

Citationchaser: A tool for transparent and efficient forward and backward citation chasing in systematic searching

10.1002/jrsm.1563 · 2022 · External reference

Unresolved reference

External reference

Development of the 25-item National Eye Institute Visual Function Questionnaire

10.1001/archopht.119.7.1050 · 2001 · External reference

Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials

10.1136/bmj-2024-081199 · 2025 · External reference

Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]

2024 · External reference

Chapter 10: Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]

2024 · External reference

Novel method for analyzing snellen visual acuity measurements

10.1097/iae.0b013e3181d87e04 · 2010 · External reference

Network Meta-analysis

10.1177/1536867x1501500403 · 2015 · External reference

A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses

10.1002/jrsm.1316 · 2019 · External reference

Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies

10.1002/jrsm.1044 · 2012 · External reference

Checking consistency in mixed treatment comparison meta-analysis

10.1002/sim.3767 · 2010 · External reference

Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression

10.1002/jrsm.1045 · 2012 · External reference

Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses

10.1503/cmaj.200077 · 2020 · External reference

GRADE guidelines: 7. Rating the quality of evidence--inconsistency

10.1016/j.jclinepi.2011.03.017 · 2011 · External reference

GRADE guidance 36: updates to GRADE’s approach to addressing inconsistency

10.1016/j.jclinepi.2023.03.003 · 2023 · External reference

GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence

10.1016/j.jclinepi.2018.11.025 · 2019 · External reference

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

2011 · External reference

Bias in meta-analysis detected by a simple, graphical test

10.1136/bmj.315.7109.629 · 1997 · External reference

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

10.1136/bmj.g5630 · 2014 · External reference

Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis

10.1016/j.jclinepi.2017.10.005 · 2018 · External reference

GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings

10.1016/j.jclinepi.2021.03.026 · 2021 · External reference

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)

10.1016/j.jclinepi.2010.07.017 · 2011 · External reference

GRADE guidelines: 8. Rating the quality of evidence--indirectness

10.1016/j.jclinepi.2011.04.014 · 2011 · External reference

GRADE guidelines: 5. Rating the quality of evidence--publication bias

10.1016/j.jclinepi.2011.01.011 · 2011 · External reference

Grading of recommendations assessment, development, and evaluation concept article 5: addressing intransitivity in a network meta-analysis

10.1016/j.jclinepi.2023.06.010 · 2023 · External reference

GRADE guidelines 33: Addressing imprecision in a network meta-analysis

10.1016/j.jclinepi.2021.07.011 · 2021 · External reference

GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework

2020 · External reference

Living systematic review: 1. Introduction-the why, what, when, and how

10.1016/j.jclinepi.2017.08.010 · 2017 · External reference

Proposed triggers for retiring a living systematic review

10.1136/bmjebm-2022-112100 · 2023 · External reference